Multiple Risk Factors in Cardiovascular Disease Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke / edited by Antonio M. Gotto Jr., Claude Lenfant, Rodolfo Paoletti, Alberico L. Catapano, Ann S. Jackson.

This volume is a collection of the most significant contributions to the 4th International Symposium on MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASE: STRATEGIES OF PREVENTION OF CORONARY HEART DISEASE, CARDIAC F AlLURE, AND STROKE held in Washington, D. C. in April 1997. The meeting focused on th...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Gotto Jr., Antonio M. (Editor), Lenfant, Claude (Editor), Paoletti, Rodolfo (Editor), Catapano, Alberico L. (Editor), Jackson, Ann S. (Editor)
Format: eBook
Language:English
Published: Dordrecht : Springer Netherlands : Imprint: Springer, 1998.
Edition:1st ed. 1998.
Series:Medical Science Symposia Series, 12
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • I. Plasma Lipids and Lipoproteins
  • New Insights into the Role of HDL in the Development of Cardiovascular Disease
  • Mechanisms of the Hypolipidemic Action of Fibrates
  • Lipid Lowering Drugs and the Arterial Wall
  • Perspectives on Lipid-Lowering Therapy: Past and Present
  • II. Coagulation, Fibrinolysis, and Platelet Inhibition
  • Role of the Fibrinolytic and the Coagulation System in the Formation and Disorders of Blood Vessels
  • Evolving Understanding of Coronary Thrombosis and New Insights into Therapeutic Strategies
  • Platelet Activation and Carotid Arterial Atherothrombosis
  • III. Emerging Risk Factors for Cardiovascular Disease
  • Tissue Factor and the Regulation of Arterial Thrombosis
  • Fibrinogen: Risk Factor or Risk Marker?
  • PAI-1 and the Risk of Cardiovascular Disease
  • Plasma Homocyst(e)ine [H(e)] and Arterial Occlusive Diseases: Gene-Nutrient Interactions
  • IV. Risk Factors and Intervention: National Initiatives
  • The Role of Social and Psychoemotional Factors in the Development of Cardiovascular Disease: The Experience in Eastern European Countries
  • European Action on Secondary Prevention
  • Cardiovascular Risk Factors in Normotensive and Hypertensive Egyptians: Preliminary Results, Egyptian National Hypertension Project (NHP)
  • V. LDL Oxidation, Antioxidants, and Atherosclerosis
  • Lipid Deposition and Oxidation in the Evolution of the Atherosclerotic Lesion: Lessons Learned from Hypercholesterolemic Animal Models
  • Oxidative Modification of LDL and Atherogenesis
  • Dietary Antioxidants and Cardiovascular Disease
  • Is “Antioxidant Status” a Risk Factor?
  • VI. Diabetes
  • Diabetes and Atherosclerosis: Risk Factors and Clinical Trials
  • Insulin Resistance: What, Why, and How
  • Diabetes
  • Dyslipidemia, Diabetes, and Cell Adhesion Molecules
  • Novel Therapeutic Approaches to Insulin Resistance/Diabetic Dyslipidemia
  • VII. Genetic Determinants of Cardiovascular Disease
  • Hypertension and Thrombosis, Genetic Determinants of Cardiovascular Disease
  • Lipoproteins and Cardiovascular Risk. From Genetics to Prevention of Coronary Heart Disease
  • Obesity and Diabetes
  • Clustering of Cardiovascular Risk Factors
  • VIII. Inflammation and Cardiovascular Disease
  • Neutrophil-Endothelial Cells Cooperation in the Handling of Leukotrienes: Role in Coronary Inflammation
  • Integrin Expression and Macrophage Resistance to Apoptosis in Atherosclerosis
  • IX. From Cholesterol to Cardiovascular Events, Where is the Bridge?
  • Effect of Statins Beyond Lowering Cholesterol: Where Do We Stand?
  • Lessons from Clinical Trials: LCAS and Other Studies
  • Improving the Cost Effectiveness of Lipid Lowering Therapy in Coronary Heart Disease Prevention
  • X. Lifestyle and Cardiovascular Disease
  • Diet and Cardiovascular Disease
  • Alcohol and Coronary Heart Disease: A Comparison of Ecologic and Non-Ecologic Studies
  • Preventing Cardiovascular Disease: Effective Smoking Cessation Strategies for the Busy Clinician
  • XI. Multiple Risk Factors and Cardiovascular Disease
  • Risk Factors for Cardiovascular Disease and the Endothelium
  • Epidemiology of Risk Factor Clustering in Elevated Blood Pressure
  • Hypertension and Coronary Heart Disease Risk Factor Management
  • Global Risk Management: New Strategies for Implementation
  • XII. Cardiac Failure
  • Sudden Cardiac Death in Heart Failure.